FATE THERAPEUTICS INC — Form 10-Q
Filed August 13, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 2/100
What the filing says
This is a routine quarterly report (10-Q) for Fate Therapeutics covering the period ending June 30, 2026, filed on August 13, 2026. The filing document header contains only standard SEC metadata (accession numbers, filing dates, document lists, company address and CIK). No specific financial data, counterparties, deal amounts, share counts, balance sheet items, or material business events are presented in the provided text excerpt.
Why this rating
Metadata-only excerpt; no substantive disclosures. Standard periodic filing with no disclosed material transactions or changes.
See more from August 13, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.